A Phase I-II dose escalation study of fixed-dose rate gemcitabine, oxaliplatin and capecitabine every two weeks in advanced cholangiocarcinomas

Ulrik Lassen, Lars Henrik Jensen, Morten Sorensen, Kristoffer S Rohrberg, Zaza Ujmajuridze, Anders Jakobsen

22 Citations (Scopus)

Fingerprint

Dive into the research topics of 'A Phase I-II dose escalation study of fixed-dose rate gemcitabine, oxaliplatin and capecitabine every two weeks in advanced cholangiocarcinomas'. Together they form a unique fingerprint.

Medicine & Life Sciences